Sort
82,697 grants matching “vaccine development”
Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune Profiling
$3,496,853Gregory A. Poland · Mayo Clinic Rochester · U01 · FY2010 · AI
Growth Control in Multiple Myeloma
$3,496,686University Of Arkansas Med Scis Ltl Rock · P01 · FY2005 · CA
INSTITUTE FOR CLINICAL AND TRANSLATIONAL RESEARCH: CLINICAL TRIALS
$3,495,002Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2007 · RR
MALARIA VACCINE DEVELOPMENT: PROTECTING OUR TROOPS
$3,495,000Seattle Biomedical Research Institute · · FY2011 · Department of Defense
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$3,493,059Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
TCR Gene Modified T Cells for Adoptive Immunotherapy
$3,493,020Michael I Nishimura · Loyola University Chicago · P01 · FY2012 · CA
THE CONTRACTOR SHALL DEVELOP AN INFRASTRUCTURE TO INTEGRATE VARIOUS TYPES OF REAL WORLD DATA FROM A VARIETY OF CLINICAL AND NONCLINICAL SOURCES IN ORD
$3,492,171Sandy Leonard · Healthverity, Inc. · N01 · FY2021 · CA
Clinical Studies of Vaccines for Pandemic Influenza
$3,490,570Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Advanced Development of Vaccines for Antibiotic Resistant Bacteria
$3,490,104Frank Malinowski · Eveliqure Biotechnologies, Gmbh · N01 · FY2023 · AI
Project 2 - GMP Manufacturing of mRNA Immunogens
$3,489,292Thomas N Denny · Duke University · U19 · FY2021 · AI
Novel cell-culture derived split influenza vaccine
$3,489,073Glaxosmithkline · UC1 · FY2004 · AI
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
$3,488,070Nicolas Collins · Vaccine Formulation Institute (Ch) Ltd · N01 · FY2024 · AI
University of Pennsylvania HIV Clinical Trials Unit
$3,487,235Ian Frank · University Of Pennsylvania · UM1 · FY2023 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$3,486,794Judith S. Currier · University Of California Los Angeles · U01 · FY2009 · AI
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
$3,485,629Cheryl L Willman · University Of New Mexico Health Scis Ctr · U2C · FY2024 · CA
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE
$3,484,773Emmanuel Walter · Duke University · N01 · FY2023 · AI
Assays to Support Development of Malaria Transmission Blocking Vaccines
$3,484,751Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Influenza and Emerging Infectious Diseases
$3,483,874Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: UNIVERSAL INFLUENZA RESEARCH ACTIVITIES
$3,483,093Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2023 · AI
Harvard University Center for AIDS Research
$3,480,242Bruce D Walker · Harvard University · P30 · FY2010 · AI
Advanced Development of Vaccines for Infectious Diseases
$3,479,950Neal Van Hoeven · Access To Advanced Health Institute · N01 · FY2022 · AI
GM-CSF-Adjuvanted Clade C DNA/MVA and MVA/MVA Vaccines
$3,478,707Harriet L Robinson · Geovax, Inc. · U19 · FY2008 · AI
Project 5: Multi-scale development and evaluation of broadly-effective vaccines against picornaviruses with pandemic potential
$3,478,173Bert L. Semler · University Of California-Irvine · U19 · FY2024 · AI
University of Washington Center for Aids Research
$3,476,634Jared Baeten · University Of Washington · P30 · FY2016 · AI
Development of an Effector-Memory T Cell AIDS Vaccine
$3,475,833Louis J. Picker · Oregon Health & Science University · P01 · FY2016 · AI